ARTICLE | Company News
Myriad Genetics Inc, BioMarin deal
April 13, 2015 7:00 AM UTC
The companies expanded a 2013 deal and BioMarin will use Myriad’s myChoice Homologous Recombination Deficiency (HRD) test to identify patients with metastatic breast and ovarian cancer that may be sen...